Folic Acid Supplementation during Pregnancy and Its Association with Telomere Length in Children at Four Years: Results from the INMA Birth Cohort Study.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
09 Oct 2023
Historique:
received: 24 08 2023
revised: 24 09 2023
accepted: 07 10 2023
medline: 23 10 2023
pubmed: 14 10 2023
entrez: 14 10 2023
Statut: epublish

Résumé

This study examined the association between folic acid supplements (FAs) during different periods of pregnancy and offspring telomere length (TL) at age four in 666 children from the INMA study. FAs were self-reported using food-structured questionnaires during three periods of pregnancy (the first three months of pregnancy, from month fourth onward, and the whole pregnancy). For each period, the average daily dosage of FAs was categorised into (i) <400 μg/d, (ii) ≥400 to 999 μg/d, (iii) ≥1000 to 4999 μg/d, and (iv) ≥5000 μg/d. Leucocyte TL at age four was measured using quantitative PCR methods. Multiple robust linear log-level regression models were used to report the % difference among FA categories. During the first period, and compared with children whose mothers were classified in the reference group (<400 μg/d), children whose mothers took higher dosages of FAs showed shorter TL at age four (≥5000 μg/d). When the first and the second periods were mutually adjusted, children whose mothers self-reported ≥5000 μg/d during the first period of pregnancy had a statistically significant shorter TL than their counterparts (% difference: -7.28% [95% CI: -14.42 to -0.13]). Similar trends were observed for the whole period of pregnancy. When the analysis was stratified by sex, the association was more evident in boys (% difference: -13.5% [95% CI: -23.0 to -4.04]), whereas no association was observed in girls. This study suggests that high dosages of FAs in the first pregnancy period may be associated with a shorter TL in children at age four, particularly among boys. Further studies should confirm these results.

Identifiants

pubmed: 37836587
pii: nu15194303
doi: 10.3390/nu15194303
pmc: PMC10574547
pii:
doi:

Substances chimiques

Folic Acid 935E97BOY8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIEHS NIH HHS
ID : 27307C0010
Pays : United States

Références

JAMA Netw Open. 2020 May 1;3(5):e204057
pubmed: 32364595
Cancer Prev Res (Phila). 2014 Jan;7(1):128-38
pubmed: 24253316
Am J Epidemiol. 2009 Dec 15;170(12):1518-29
pubmed: 19903723
Annu Rev Public Health. 2020 Apr 2;41:223-245
pubmed: 31900099
Stress. 2020 Sep;23(5):597-606
pubmed: 32063089
Nutr J. 2013 Feb 19;12:26
pubmed: 23421854
Genome Biol. 2007;8(2):R19
pubmed: 17291332
Ann Nutr Metab. 2015;66(4):202-8
pubmed: 26067849
Am J Epidemiol. 2021 Jul 1;190(7):1406-1413
pubmed: 33564874
Am J Clin Nutr. 1997 Jun;65(6):1790-5
pubmed: 9174474
EBioMedicine. 2021 Jan;63:103164
pubmed: 33422989
Biomolecules. 2022 Jan 24;12(2):
pubmed: 35204698
Curr Drug Metab. 2012 Oct;13(8):1184-95
pubmed: 22746304
Aging Cell. 2013 Aug;12(4):615-21
pubmed: 23601089
Mol Nutr Food Res. 2013 Apr;57(4):582-95
pubmed: 23213022
Ann N Y Acad Sci. 2011 Jul;1229:76-88
pubmed: 21793842
Eur J Nutr. 2015 Mar;54(2):235-41
pubmed: 24793435
Aging Cell. 2022 May;21(5):e13614
pubmed: 35441417
Philos Trans R Soc Lond B Biol Sci. 2018 Mar 5;373(1741):
pubmed: 29335378
J Nutr. 2006 Jan;136(1):189-94
pubmed: 16365081
JAMA Pediatr. 2014 Nov;168(11):e142611
pubmed: 25365251
Adv Nutr. 2012 Jan;3(1):21-38
pubmed: 22332098
Clin Chem Lab Med. 2018 Jul 26;56(8):1210-1222
pubmed: 29494336
Br J Nutr. 2003 Aug;90(2):473-9
pubmed: 12908910
Clin Chem Lab Med. 2020 Jan 28;58(2):162-177
pubmed: 31465289
Philos Trans R Soc Lond B Biol Sci. 2018 Mar 5;373(1741):
pubmed: 29335381
Nutr Rev. 2021 Jan 9;79(2):148-159
pubmed: 32968801
Am J Clin Nutr. 2017 Sep;106(3):878-887
pubmed: 28724645
Subcell Biochem. 2018;90:221-308
pubmed: 30779012
Public Health Nutr. 2018 Jan;21(1):5-17
pubmed: 28322183
Am J Clin Nutr. 2008 Mar;87(3):517-33
pubmed: 18326588
Sci Rep. 2019 Jul 17;9(1):10359
pubmed: 31316106

Auteurs

Fanny Petermann-Rocha (F)

Centro de Investigación Biomédica, Facultad de Medicina, Universidad Diego Portales, Santiago 8370109, Chile.

Desirée Valera-Gran (D)

Department of Surgery and Pathology, Miguel Hernandez University, 03550 Alicante, Spain.
Grupo de Investigación en Terapia Ocupacional (InTeO), Miguel Hernandez University, 03550 Alicante, Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernández (ISABIAL-UMH), 03010 Alicante, Spain.

Daniel Prieto-Botella (D)

Department of Surgery and Pathology, Miguel Hernandez University, 03550 Alicante, Spain.
Grupo de Investigación en Terapia Ocupacional (InTeO), Miguel Hernandez University, 03550 Alicante, Spain.

Dries S Martens (DS)

Centre for Environmental Sciences, Hasselt University, 3590 Hasselt, Belgium.

Sandra Gonzalez-Palacios (S)

Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernández (ISABIAL-UMH), 03010 Alicante, Spain.
CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Unidad de Epidemiología de la Nutrición (EPINUT), Departamento de Salud Pública, Historia de la Ciencia y Ginecología, Universidad Miguel Hernández (UMH), 03550 Alicante, Spain.

Isolina Riaño-Galán (I)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA), University of Oviedo, 33003 Oviedo, Spain.
Pediatrics Unit, Central University Hospital of Asturias, 33011 Oviedo, Spain.

Mario Murcia (M)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Epidemiology and Environmental Health Joint Research Unit, FISABIO-Universitat Jaume I-Universitat de València, 46020 Valencia, Spain.
Servicio de Análisis de Sistemas de Información Sanitaria, Conselleria de Sanitat, Generalitat Valenciana, 46010 Valencia, Spain.

Amaia Irizar (A)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Department of Preventive Medicine and Public Health, Faculty of Medicine and Nursing, University of the Basque Country, 48940 Leioa, Spain.
Group of Environmental Epidemiology and Child Development, Biodonostia Health Institute, 20014 San Sebastian, Spain.

Jordi Julvez (J)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Clinical and Epidemiological Neuroscience Group (NeuroÈpia), Institut d'Investigació Sanitària Pere Virgili (IISPV), 43204 Reus, Spain.
Instituto de Salud Global (ISGlobal) de Barcelona Campus MAR, Parc de Recerca Biomèdica de Barcelona (PRBB), 08003 Barcelona, Spain.

Loreto Santa-Marina (L)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Group of Environmental Epidemiology and Child Development, Biodonostia Health Institute, 20014 San Sebastian, Spain.
Health Department of Basque Government, Sub-Directorate of Public Health of Gipuzkoa, 20013 San Sebastian, Spain.

Adonina Tardón (A)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA), University of Oviedo, 33003 Oviedo, Spain.
Instituto Universitario de Oncología Del Principado de Asturias (IUOPA), Departamento de Medicina, University of Oviedo, 33006 Oviedo, Spain.

Jordi Sunyer (J)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Instituto de Salud Global (ISGlobal) de Barcelona Campus MAR, Parc de Recerca Biomèdica de Barcelona (PRBB), 08003 Barcelona, Spain.
Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, 08002 Barcelona, Spain.

Jesús Vioque (J)

Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernández (ISABIAL-UMH), 03010 Alicante, Spain.
CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Unidad de Epidemiología de la Nutrición (EPINUT), Departamento de Salud Pública, Historia de la Ciencia y Ginecología, Universidad Miguel Hernández (UMH), 03550 Alicante, Spain.

Tim Nawrot (T)

Centre for Environmental Sciences, Hasselt University, 3590 Hasselt, Belgium.

Eva-María Navarrete-Muñoz (EM)

Department of Surgery and Pathology, Miguel Hernandez University, 03550 Alicante, Spain.
Grupo de Investigación en Terapia Ocupacional (InTeO), Miguel Hernandez University, 03550 Alicante, Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernández (ISABIAL-UMH), 03010 Alicante, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH